Vaccine 4 1 1 for 7-02-2020 - tracking the race to find a cure for the Coronavirus - Covid 19

<p>On this episode of Vaccine 411… Could the FDA delay a potential COVID-19 vaccine?</p><p>First, the latest vaccine news from around the world:&nbsp;</p><p>United States and Germany:&nbsp;US based Pfizer and German based BioNTech published data this week that Phase I trials of their vaccine candidate have proven safe and produce a higher immune response in subjects than patients that have recovered from the virus. Pending approval, they will move to Phase III with 30,000 subjects by the end of July.&nbsp;</p><p>Also in the U.S., Pennsylvania based Inovio, reported their vaccine is safe and they have seen immune responses.&nbsp;They plan to move to Phase II/III trials by August</p><p>Japan:&nbsp;Agnes Inc, began the first human trials for a vaccine candidate in Japan.&nbsp;The DNA vaccine will be tested on 30 healthy adults, they will review the data in two months.&nbsp;</p><p>India:&nbsp;Bharat Biotech’s vaccine candidate Covaxin has been cleared for Phase I human trials.&nbsp;This is the first candidate developed in India.</p> &#10;&nbsp;<br /><hr><p style='color: grey; font - size: 0.75em; '>See <a style='color: grey; ' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>